Antipsychotics

Printable VersionPrintable Version

Article

Prescribing Atypical Antipsychotics: What are the Risks?

Over the past several years, the use of antipsychotics has expanded dramatically. Aside from the traditional indication, schizophrenia, various members of this class have received FDA approval for bipolar mania, bipolar depression, major depression, and autism, and increasingly they are used off-label for anxiety, insomnia, and agitation.

Saphris and Fanapt: Two New Antipsychotics

You've probably heard about Fanapt (iloperidone) and Saphris (asenapine), two antipsychotics that have recently won FDA approval for the acute treatment of schizophrenia, and, in the case of Saphris, for the treatment of manic and mixed episodes of bipolar disorder. Are these more “me too”...

Typical Antipsychotics: A Brief Review

Those of us who completed residency anytime during the last 10 years were indoctrinated against the use of conventional neuroleptics because of their array of side effects, particularly extrapyramidal syndromes (EPS) and tardive dyskinesia (TD).
more

Research Update

Antipsychotics: Small Benefits for Depression

Short Description: 
Antipsychotics: Small Benefits for Depression

Abilify for Depression and Bipolar Disorder: A Meta-Analysis

Short Description: 
Abilify for Depression and Bipolar Disorder: A Meta-Analysis
more

Expert QA

more

Medication Fact Sheet

more